Thursday, September 10, 2015

Pfizer loses UK patent case over use of Lyrica drug in pain

LONDON (Reuters) - Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that its claims of general patent protection for the use of its $5 billion-a-year drug Lyrica in pain were invalid.











Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49bb4567/sc/3/l/0L0Sreuters0N0Carticle0C20A150C0A90C10A0Cus0Epfizer0Ebritain0Elyrica0EidUSKCN0ARA1G120A150A910A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

No comments:

Post a Comment